title: Improving breast cancer therapy with CDK4/6 inhibitors.
authors.affiliation: Medical Affairs, Imedex, LLC, Alpharetta, GA. Electronic address: h.jaganathan@imedex.com.
authors.forename: Hamsa
authors.initials: H
authors.lastname: Jaganathan
authors.affiliation: Medical Affairs, Imedex, LLC, Alpharetta, GA.
authors.forename: Karen
authors.initials: K
authors.lastname: Overstreet
authors.affiliation: Division of Hematology and Oncology, University of Nebraska Medical Center, Omaha, NE.
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Reed
mesh_terms: D000818:Animals; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000201:enzymology; D051358:Cyclin-Dependent Kinase 4 / Q000037:antagonists & inhibitors*; D051361:Cyclin-Dependent Kinase 6 / Q000037:antagonists & inhibitors*; D005260:Female; D006801:Humans; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*
chemical_list: D047428:Protein Kinase Inhibitors; D051358:Cyclin-Dependent Kinase 4; D051361:Cyclin-Dependent Kinase 6